[go: up one dir, main page]

NO127425B - - Google Patents

Download PDF

Info

Publication number
NO127425B
NO127425B NO00168765A NO16876567A NO127425B NO 127425 B NO127425 B NO 127425B NO 00168765 A NO00168765 A NO 00168765A NO 16876567 A NO16876567 A NO 16876567A NO 127425 B NO127425 B NO 127425B
Authority
NO
Norway
Prior art keywords
solution
queen bee
solvent
sap
filtered
Prior art date
Application number
NO00168765A
Other languages
Norwegian (no)
Inventor
Andrew Oakley Dubois
Original Assignee
Libbey Owens Ford Glass Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Libbey Owens Ford Glass Co filed Critical Libbey Owens Ford Glass Co
Publication of NO127425B publication Critical patent/NO127425B/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23CCOATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C14/00Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material
    • C23C14/22Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material characterised by the process of coating
    • C23C14/24Vacuum evaporation
    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23CCOATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C14/00Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material
    • C23C14/22Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material characterised by the process of coating
    • C23C14/56Apparatus specially adapted for continuous coating; Arrangements for maintaining the vacuum, e.g. vacuum locks

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Mechanical Engineering (AREA)
  • Metallurgy (AREA)
  • Organic Chemistry (AREA)
  • Physical Vapour Deposition (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Sealing Using Fluids, Sealing Without Contact, And Removal Of Oil (AREA)
  • Vaporization, Distillation, Condensation, Sublimation, And Cold Traps (AREA)

Description

Fremgangsmåte for fremstilling av injiserbare oppløsninger av bidronningforsaft. Process for the production of injectable solutions of queen bee sap.

Det er tidligere kjent at bidronningforsaft administret oralt eller perkutant It is previously known that queen bee juice is administered orally or percutaneously

har en utmerket roborerende virkning på has an excellent roboring effect on

almentilstanden, henholdsvis på den be-handlede hud, særlig hos aldrende men-nesker. Det var hittil ikke mulig klinisk å the general condition, respectively on the treated skin, especially in aging people. It was not possible until now clinically to

fastlegge virkningen av bidronningforsaften på den menneskelige organisme enty-dig, og likeså litt kunne man forhindre determine the effect of the queen bee juice on the human organism unequivocally, and just as little could be prevented

opptreden av ikke ønskede bivirkninger ved appearance of unwanted side effects by

behandlingen. the treatment.

Nærværende oppfinnelse angår nå en The present invention now relates to a

fremgangsmåte for fremstilling av injiserbare oppløsninger av bidronningforsaft, method for producing injectable solutions of queen bee juice,

ved hvilken det er blitt mulig å fastlegge by which it has become possible to determine

virkningen vesentlig mere eksakt og ut-preget, og samtidig unngå at ikke ønskede the effect significantly more exact and distinct, and at the same time avoid that you did not want

bivirkninger opptrer. side effects occur.

Oppfinnelsen består i at bidronningforsaft behandles så lenge med vann, inntil størstedelen av det virksomme stoff er The invention consists in treating bee sap for a long time with water, until the majority of the active substance is

gått i oppløsning, og felles ut fra oppløs-ningen og skilles fra de eggehviteholdige dissolved, and precipitated from the solution and separated from those containing egg whites

stoffer ved opphetning eller ved tilsetning substances by heating or by addition

av organiske oppløsningsmidler. Etter fore-liggende oppfinnelse kan man ryste bidronningforsaften med destillert vann i of organic solvents. According to the present invention, the queen bee juice can be shaken with distilled water in it

flere timer, derpå oppvarmes langsomt under stadig omrøring til 90°, ved hvilken several hours, then slowly heated with constant stirring to 90°, at which

temperatur væsken holdes 2—30 minutter temperature the liquid is kept for 2-30 minutes

under omrøring. De virksomme stoffer har while stirring. The active substances have

ved denne behandling spaltet seg fra egge-hvitemolekylene og foreligger nå i vandig by this treatment split from the egg-white molecules and is now present in water

oppløsning, som kan filtreres fra og fylles solution, which can be filtered from and filled

i ampuller. in ampoules.

Etter en ytterligere utformning av After a further design of

fremgangsmåten kan man også koke opp the method can also be boiled

Claims (3)

bidronningforsaften i isoton koksaltopp-løsning og derpå digerere 24 timer under stadig omrøring. Oppløsningen filtreres og fylles i ampuller. Endelig kan man også fremstille en vandig oppslemning av bidronningforsaft, gjøre denne homogen og langsomt tilsette den et organisk oppløs-ningsmiddel, som aceton eller en lavere alkohol. Etter at bunnfallet har avsatt seg tilsettes den ovenstående klare oppløsning ytterligere oppløsningsmiddel inntil ingen ny blakking lenger oppstår. Derpå filtreres oppløsningen fra det uoppløste og opp-løsningsmidlet destilleres av i vakuum. Oppløsningen blir derpå bragt på den ønskede konsentrasjon og fylles i ampuller.the queen bee sap in isotonic saline solution and then digest for 24 hours with constant stirring. The solution is filtered and filled into ampoules. Finally, you can also prepare an aqueous slurry of queen bee sap, make this homogeneous and slowly add an organic solvent to it, such as acetone or a lower alcohol. After the precipitate has settled, additional solvent is added to the above clear solution until no further clouding occurs. The solution is then filtered from the undissolved and the solvent is distilled off in a vacuum. The solution is then brought to the desired concentration and filled into ampoules. 1. Fremgangsmåte for fremstilling av injiserbare oppløsninger av bidronningforsaft, karakterisert ved at bidronningforsaften behandles så lenge med vann inntil størsteparten av det virksomme stoff er gått i oppløsning, og at de eggehviteholdige stoffer felles ut og skilles fra opp-løsningen ved oppvarmning eller ved tilsetning av organiske oppløsningsmidler. 1. Process for the production of injectable solutions of queen bee juice, characterized in that the queen bee juice is treated with water until most of the active substance has dissolved, and that the substances containing egg white are precipitated and separated from the solution by heating or by adding organic solvents. 2. Fremgangsmåte etter påstand 1, karakterisert ved at bidronningforsaften rystes flere timer med destillert vann, derpå oppvarmes under stadig omrøring til 90°, holdes på denne temperatur under om-røring 2—30 minutter og derpå filtreres. 2. Method according to claim 1, characterized in that the queen bee sap is shaken for several hours with distilled water, then heated with constant stirring to 90°, kept at this temperature with stirring for 2-30 minutes and then filtered. 3. Fremgangsmåte etter påstand 1, karakterisert ved at bidronningforsaft ko-kes opp i isoton koksaltoppløsning og di-gereres 24 timer under stadig omrøring, hvorpå oppløsningen filtreres. Fremgangsmåte etter påstand 1, karakterisert ved at bidronningforsaft slemmes opp i destillert vann, tilsettes under omrøring et organisk oppløsningsmid-del som en lavere alkohol eller aceton, bunnfallet får avsette seg, hvorpå den ovenstående klare oppløsning tilsettes yt terligere oppløsningsmiddel inntil ytterligere blakking ikke lenger inntrer, hvorpå oppløsningsmidlet etter avfiltrering av fel-lingen, destilleres av i vakuum og oppløs-ningen bringes på den ønskede konsentrasjon.3. Method according to claim 1, characterized in that queen bee juice is boiled in isotonic saline solution and digested for 24 hours with constant stirring, after which the solution is filtered. Method according to claim 1, characterized in that queen bee sap is slurried in distilled water, an organic solvent such as a lower alcohol or acetone is added while stirring, the precipitate is allowed to settle, after which the above clear solution is added to the more solvent until further clouding no longer occurs, after which the solvent, after filtering off the precipitate, is distilled off in a vacuum and the solution is brought to the desired concentration.
NO00168765A 1966-07-13 1967-06-27 NO127425B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US564811A US3360600A (en) 1966-07-13 1966-07-13 Vapor source assembly

Publications (1)

Publication Number Publication Date
NO127425B true NO127425B (en) 1973-06-18

Family

ID=24255989

Family Applications (1)

Application Number Title Priority Date Filing Date
NO00168765A NO127425B (en) 1966-07-13 1967-06-27

Country Status (10)

Country Link
US (1) US3360600A (en)
AT (1) AT294511B (en)
BE (1) BE701306A (en)
CH (1) CH463232A (en)
ES (1) ES342858A1 (en)
GB (1) GB1151126A (en)
LU (1) LU53955A1 (en)
NL (1) NL6709464A (en)
NO (1) NO127425B (en)
SE (1) SE335269B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3502499A (en) * 1967-05-22 1970-03-24 Texas Instruments Inc Cladding method and apparatus
US3613633A (en) * 1970-03-18 1971-10-19 Schjeldahl Co G T Method and apparatus for coating articles utilizing rotating crucible coating apparatus including a centrifugal-type crucible
US4048462A (en) * 1975-01-17 1977-09-13 Airco, Inc. Compact rotary evaporation source
DE2519537C2 (en) * 1975-05-02 1982-11-04 Leybold-Heraeus GmbH, 5000 Köln Electron beam device for heating, melting and evaporation purposes with deflection systems
DE3228311C2 (en) * 1982-07-29 1984-07-05 Leybold-Heraeus GmbH, 5000 Köln Evaporation crucible for vacuum evaporation systems
KR101785562B1 (en) * 2010-10-18 2017-10-18 삼성디스플레이 주식회사 Thin film depositing apparatus for continuous depositing and mask unit and crucible unit included in the thin film depositing apparatus

Also Published As

Publication number Publication date
NL6709464A (en) 1968-01-15
BE701306A (en) 1967-12-18
US3360600A (en) 1967-12-26
CH463232A (en) 1968-09-30
DE1621203A1 (en) 1971-06-03
ES342858A1 (en) 1968-08-16
AT294511B (en) 1971-11-25
DE1621203B2 (en) 1972-12-28
SE335269B (en) 1971-05-17
LU53955A1 (en) 1967-08-28
GB1151126A (en) 1969-05-07

Similar Documents

Publication Publication Date Title
Carsten Uterine smooth muscle: Troponin
CN109776652B (en) Cod skin oligopeptide and its separation and purification method and its application in the preparation of α-glucosidase inhibitors and anti-type Ⅱ diabetes drugs
NO127425B (en)
DE1692206B1 (en) Process for the production of candied fruits
DE2558537C2 (en) Method for isolating substances with insulin-like activity from blood or blood components of calves or pigs
GB692284A (en) Stable syrup of high dextrine content and method of manufacturing same
SU145878A1 (en) Method of accelerating the ripening of horse alcohols
CN111004305B (en) Agaricus blazei small peptide and its preparation method and application
DE575546C (en) Process for the production of a special wort
SU93810A1 (en) The method of preparation of protein food preparation
KR102154397B1 (en) The method of vitamin C-used fermentation of pig skin
RU2078345C1 (en) Method of preparing serum protein preparations influencing activity of oxidative energetic exchange
CN113215215A (en) Preparation method of albumin active peptide based on enzymolysis of egg white
KR102700157B1 (en) Manufacturing Method of Egg White Microsomal Fraction, and Egg White Microsomal Fraction Manufactured by the Same
CN119792156B (en) Composition with anti-inflammatory and anti-aging effects and application thereof
RU2828278C1 (en) Method for producing biologically active supplement from hydrobionts gonads
SU1108095A2 (en) Method of obtaining fish glue
AT203633B (en) Process for the preparation of injectable solutions from royal jelly
US1568196A (en) Vitamine preparation and a process of making same
RU2747629C1 (en) Method for producing jelly fruit-vegetable marmalade enriched with biologically active substances leuzea safflower and chaga
US1680660A (en) Parathyroid product
SU63664A1 (en) The method of obtaining albumin and other proteins from the blood for technical purposes
GB306464A (en) Process for producing solutions adapted to be spun
DE1150779B (en) Process for obtaining organ preparations with a spasmolytic effect
CN106109436A (en) A kind of preparation method of ethyl linolenate soft capsule